Search by Drug Name or NDC
NDC 68462-0409-60 propafenone hydrochloride 325 mg/1 Details
propafenone hydrochloride 325 mg/1
propafenone hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is PROPAFENONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Propafenone is used to treat arrhythmia (irregular heartbeat) and to maintain a normal heart rate. Propafenone is in a class of medications called antiarrhythmics. It works by acting on the heart muscle to improve the heart's rhythm.
Related Packages: 68462-0409-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Propafenone
Product Information
| NDC | 68462-0409 |
|---|---|
| Product ID | 68462-409_064ec508-4c51-41fa-929f-0abe45b4779b |
| Associated GPIs | 35300050006930 |
| GCN Sequence Number | 053540 |
| GCN Sequence Number Description | propafenone HCl CAP ER 12H 325 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 21058 |
| HICL Sequence Number | 004833 |
| HICL Sequence Number Description | PROPAFENONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | propafenone hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | propafenone hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 325 |
| Active Ingredient Units | mg/1 |
| Substance Name | PROPAFENONE HYDROCHLORIDE |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205268 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0409-60 (68462040960)
| NDC Package Code | 68462-409-60 |
|---|---|
| Billing NDC | 68462040960 |
| Package | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-409-60) |
| Marketing Start Date | 2017-09-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.44175 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | PROPAFENONE HCL ER 325 MG CAP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis